Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen Biomarkers in High-Risk Breast Cancer
NCT00096369Phase 2Terminated
- Sponsor
- UT Southwestern Medical Center
- Start
- Feb 2000
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tamoxifen in breast cancer, sponsored by UT Southwestern Medical Center. Started Feb 2000; status: terminated.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00096369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00096369.